Browsing Tag
NSE
148 posts
Orchid Pharma company profile: business model, financials, and growth outlook (2026 Edition)
Orchid Pharma Limited company profile: cephalosporin API leader, FY2025 revenue Rs. 921.93 Cr, Jammu PLI expansion, novel antibiotic pipeline, and 2026-27 growth outlook.
Titan Company (NSE: TITAN) after a record FY26: The bull case, the risks and what comes next
Titan Company (NSE: TITAN) Q4 FY26 jewellery sales up 57.6%. Full-year results due. CLSA target Rs 4,996, UBS Rs 5,300. Risks and outlook for retail investors.
Dev Information Technology (NSE: DEVIT) to offload ByteSIGNER and Talligence as XDuce partnership reshapes strategic direction
Dev Information Technology transfers ByteSIGNER and Talligence to an associate for Rs 11.90 crore as XDuce's 24% stake signals a bold services-only pivot. Read the full analysis.
Saharsh Davuluri takes helm at Neuland Laboratories as CDMO accelerates push into commercial NCE contracts
Saharsh Davuluri takes over as CEO of Neuland Laboratories, steering the Indian CDMO into an aggressive peptide and NCE expansion. Read what this means for investors and competitors.
Rain Industries (NSE: RAIN) and Green Graphite Technologies complete graphite purification project as Ontario eyes domestic battery supply chain independence
Rain Industries unit Rain Carbon Canada completes battery graphite pilot with Green Graphite Technologies. What it means for RAIN stock. Read the full analysis.
PhysicsWallah (NSE: PWL) kicks off FY27 academic cycle with Rs 205cr Vishwas Diwas collections, posting 36% year-on-year growth
PhysicsWallah reports Rs 205 crore Vishwas Diwas collections, 36% YoY growth, 439K enrollments. What it means for PWL stock and India edtech. Read more.
Alembic Pharmaceuticals (APLLTD) wins FDA final approval for Paroxetine Extended-Release Tablets
Alembic Pharmaceuticals (APLLTD) wins USFDA final approval for Paroxetine ER 12.5 mg tablets. Read what it means for the US generic pipeline and investor outlook.
Ola Electric’s #EndICEAge campaign slashes entry price to Rs 49,999 to reclaim lost ground in India’s electric two-wheeler market
Ola Electric slashes prices to Rs 49,999 and launches buyback and service guarantees. Is the #EndICEAge campaign enough to reverse India's most dramatic EV market share collapse? Read more.
LTTS to divest SWC business to AMI Paradigm in Rs 452cr slump sale
LTTS to sell its Smart World and Communication unit for Rs 452 crore to refocus on Engineering Intelligence. Read the full strategic analysis here.
Infosys agrees to acquire Optimum Healthcare IT for $465m in its second-largest deal, targeting AI-led transformation of US provider market
Infosys to acquire Optimum Healthcare IT for $465M to lead AI-driven US health system transformation. Read the full strategic and market analysis.